Acciones Tetra Bio Pharma Inc Canadian Securities Exchange
Acciones
TBP
CA88166Y1007
Farmacéuticos
Ventas 2020 | - | Ventas 2021 | - | Capitalización | 88,81 M 121 M 82,89 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -26 M -35,51 M -24,27 M | Resultado Neto 2021 | -52 M -71,01 M -48,54 M | VE / Ventas 2020 | - |
Posición de caja neta 2020 | 501 mil 684 mil 467 mil | Posición de caja neta 2021 | 1,77 M 2,42 M 1,66 M | VE / Ventas 2021 | - |
P/E ratio 2020 |
-1,86
x | P/E ratio 2021 |
-1,7
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 99,01 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01/06/16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01/06/16 |
Catherine Auld
BRD | Director/Board Member | - | 28/05/21 |
H. Norton
CHM | Chairman | 63 | 17/09/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,76 % | 5677,95 M | |
-32,34 % | 3592,89 M | |
-2,23 % | 3121,15 M | |
-25,26 % | 2624,14 M | |
-10,88 % | 2301,56 M | |
+40,09 % | 1880,89 M | |
+40,90 % | 1451,34 M | |
-15,16 % | 1393,6 M | |
+42,86 % | 1372,45 M |